Figure 2.
Subsequent change in molecular response. A, total patients; B, imatinib‐treated patients; C, 2G TKI‐treated patients; N (%)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.